 Suet Nee Chen
Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathies | 11 | 2025 | 330 | 3.330 |
Why?
| | Lamin Type A | 7 | 2021 | 45 | 1.920 |
Why?
| | Cardiomyopathy, Dilated | 5 | 2021 | 337 | 1.800 |
Why?
| | Arrhythmias, Cardiac | 6 | 2025 | 332 | 1.630 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2024 | 265 | 1.290 |
Why?
| | Myocytes, Cardiac | 12 | 2024 | 535 | 1.210 |
Why?
| | Filamins | 4 | 2025 | 27 | 1.160 |
Why?
| | Cardiomyopathy, Hypertrophic | 10 | 2024 | 141 | 1.020 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 2 | 2017 | 57 | 0.920 |
Why?
| | Death, Sudden, Cardiac | 2 | 2025 | 190 | 0.770 |
Why?
| | Transposition of Great Vessels | 1 | 2022 | 40 | 0.760 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2022 | 45 | 0.750 |
Why?
| | Coronary Artery Disease | 4 | 2009 | 702 | 0.670 |
Why?
| | DNA Damage | 2 | 2021 | 427 | 0.630 |
Why?
| | Mutation | 9 | 2024 | 4013 | 0.630 |
Why?
| | Myocardium | 7 | 2024 | 928 | 0.550 |
Why?
| | Biology | 1 | 2018 | 92 | 0.520 |
Why?
| | Research Personnel | 1 | 2018 | 183 | 0.480 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2021 | 528 | 0.480 |
Why?
| | Muscle Proteins | 3 | 2012 | 240 | 0.480 |
Why?
| | Signal Transduction | 7 | 2024 | 5144 | 0.460 |
Why?
| | Mutation, Missense | 3 | 2021 | 339 | 0.420 |
Why?
| | Adipogenesis | 1 | 2013 | 57 | 0.400 |
Why?
| | Motivation | 1 | 2018 | 602 | 0.390 |
Why?
| | Gene Deletion | 2 | 2016 | 388 | 0.360 |
Why?
| | Cholesterol, HDL | 2 | 2009 | 196 | 0.350 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2012 | 175 | 0.340 |
Why?
| | Myofibroblasts | 2 | 2022 | 128 | 0.330 |
Why?
| | Sarcomeres | 2 | 2024 | 94 | 0.300 |
Why?
| | Genetic Association Studies | 1 | 2009 | 372 | 0.270 |
Why?
| | Haplotypes | 3 | 2007 | 496 | 0.260 |
Why?
| | Fibrosis | 7 | 2022 | 541 | 0.260 |
Why?
| | Humans | 29 | 2025 | 141187 | 0.240 |
Why?
| | Hyperlipoproteinemia Type II | 1 | 2005 | 32 | 0.220 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2009 | 2132 | 0.220 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2024 | 119 | 0.220 |
Why?
| | Genetic Predisposition to Disease | 4 | 2021 | 2363 | 0.220 |
Why?
| | Serine Endopeptidases | 1 | 2005 | 119 | 0.220 |
Why?
| | Animals | 17 | 2022 | 37657 | 0.210 |
Why?
| | Genetic Markers | 1 | 2005 | 343 | 0.210 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2024 | 37 | 0.210 |
Why?
| | Hypolipidemic Agents | 1 | 2004 | 92 | 0.200 |
Why?
| | Cell Adhesion | 2 | 2021 | 468 | 0.200 |
Why?
| | Echocardiography | 3 | 2024 | 643 | 0.200 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 209 | 0.180 |
Why?
| | Genotype | 4 | 2009 | 1859 | 0.180 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2024 | 231 | 0.180 |
Why?
| | Calcineurin | 2 | 2012 | 107 | 0.180 |
Why?
| | Microtechnology | 1 | 2021 | 8 | 0.180 |
Why?
| | Ion Channels | 2 | 2022 | 130 | 0.180 |
Why?
| | Haploinsufficiency | 1 | 2021 | 56 | 0.180 |
Why?
| | Heterozygote | 4 | 2025 | 307 | 0.170 |
Why?
| | Phenotype | 10 | 2025 | 3166 | 0.170 |
Why?
| | Carrier Proteins | 4 | 2024 | 740 | 0.170 |
Why?
| | Arteries | 1 | 2022 | 263 | 0.170 |
Why?
| | Desmosomes | 2 | 2017 | 21 | 0.170 |
Why?
| | Mechanical Phenomena | 1 | 2021 | 85 | 0.170 |
Why?
| | Mice | 10 | 2022 | 18048 | 0.170 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2020 | 18 | 0.170 |
Why?
| | Genetic Variation | 1 | 2005 | 1000 | 0.160 |
Why?
| | DNA Repair | 1 | 2021 | 234 | 0.150 |
Why?
| | Cellular Senescence | 1 | 2021 | 205 | 0.150 |
Why?
| | E2F Transcription Factors | 1 | 2019 | 62 | 0.150 |
Why?
| | Lipids | 1 | 2004 | 689 | 0.150 |
Why?
| | Genetic Testing | 1 | 2021 | 460 | 0.140 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 173 | 0.140 |
Why?
| | Myocardial Contraction | 2 | 2018 | 303 | 0.140 |
Why?
| | Gene Frequency | 3 | 2009 | 494 | 0.140 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 35 | 0.140 |
Why?
| | Work-Life Balance | 1 | 2018 | 22 | 0.140 |
Why?
| | Fatty Acids, Monounsaturated | 2 | 2009 | 53 | 0.130 |
Why?
| | Myosin Heavy Chains | 4 | 2024 | 180 | 0.130 |
Why?
| | Acetylcysteine | 2 | 2009 | 142 | 0.130 |
Why?
| | Desmoplakins | 1 | 2016 | 20 | 0.120 |
Why?
| | Heart Ventricles | 1 | 2021 | 752 | 0.120 |
Why?
| | Linkage Disequilibrium | 2 | 2009 | 255 | 0.120 |
Why?
| | Microscopy, Atomic Force | 3 | 2021 | 128 | 0.120 |
Why?
| | Transcription Factors | 1 | 2004 | 1703 | 0.120 |
Why?
| | Fibroblasts | 2 | 2022 | 1020 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2021 | 1154 | 0.110 |
Why?
| | Apoptosis | 3 | 2021 | 2574 | 0.110 |
Why?
| | Adipocytes | 1 | 2016 | 227 | 0.110 |
Why?
| | Mice, Knockout | 3 | 2021 | 3068 | 0.100 |
Why?
| | Antioxidants | 2 | 2009 | 595 | 0.100 |
Why?
| | Indoles | 2 | 2009 | 429 | 0.100 |
Why?
| | Mice, Transgenic | 4 | 2012 | 2180 | 0.100 |
Why?
| | Risk Factors | 2 | 2022 | 10438 | 0.100 |
Why?
| | Male | 12 | 2025 | 69783 | 0.100 |
Why?
| | Tripartite Motif Proteins | 1 | 2012 | 41 | 0.090 |
Why?
| | Genomics | 1 | 2017 | 814 | 0.090 |
Why?
| | Triglycerides | 2 | 2005 | 514 | 0.090 |
Why?
| | Female | 12 | 2025 | 75515 | 0.090 |
Why?
| | Stem Cells | 1 | 2016 | 602 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 703 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2504 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2599 | 0.090 |
Why?
| | Cells, Cultured | 5 | 2021 | 4208 | 0.090 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2158 | 0.080 |
Why?
| | Models, Animal | 1 | 2012 | 396 | 0.080 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2929 | 0.080 |
Why?
| | Apolipoprotein A-I | 1 | 2009 | 30 | 0.080 |
Why?
| | Middle Aged | 7 | 2025 | 34434 | 0.080 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2009 | 39 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 423 | 0.080 |
Why?
| | Heart Failure, Systolic | 1 | 2009 | 25 | 0.070 |
Why?
| | Disease Models, Animal | 5 | 2021 | 4404 | 0.070 |
Why?
| | Genes, Dominant | 2 | 2007 | 97 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2016 | 2003 | 0.070 |
Why?
| | Cell Line | 1 | 2013 | 2885 | 0.070 |
Why?
| | Biomechanical Phenomena | 2 | 2024 | 835 | 0.070 |
Why?
| | DNA Mutational Analysis | 2 | 2007 | 398 | 0.070 |
Why?
| | Troponin T | 2 | 2024 | 66 | 0.070 |
Why?
| | Sulfhydryl Compounds | 1 | 2009 | 188 | 0.060 |
Why?
| | Phosphorylation | 3 | 2021 | 1768 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2018 | 281 | 0.060 |
Why?
| | Rats | 4 | 2021 | 5629 | 0.060 |
Why?
| | Alleles | 1 | 2009 | 891 | 0.060 |
Why?
| | Cholesterol | 2 | 2005 | 405 | 0.060 |
Why?
| | Chromosome Mapping | 1 | 2007 | 504 | 0.060 |
Why?
| | Actins | 2 | 2024 | 423 | 0.060 |
Why?
| | Proprotein Convertases | 1 | 2005 | 16 | 0.060 |
Why?
| | Heptanoic Acids | 1 | 2005 | 66 | 0.060 |
Why?
| | Quantitative Trait Loci | 1 | 2007 | 364 | 0.060 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2025 | 56 | 0.060 |
Why?
| | Proprotein Convertase 9 | 1 | 2005 | 78 | 0.060 |
Why?
| | Pedigree | 2 | 2021 | 511 | 0.060 |
Why?
| | Aged | 4 | 2009 | 24574 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 386 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2012 | 3588 | 0.050 |
Why?
| | Lipoprotein(a) | 1 | 2005 | 68 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2005 | 160 | 0.050 |
Why?
| | Cardiac Myosins | 1 | 2024 | 34 | 0.050 |
Why?
| | Pyrroles | 1 | 2005 | 210 | 0.050 |
Why?
| | Aldosterone | 1 | 2004 | 43 | 0.050 |
Why?
| | Pharmacogenetics | 1 | 2005 | 167 | 0.050 |
Why?
| | Multifactorial Inheritance | 1 | 2005 | 178 | 0.050 |
Why?
| | Adult | 5 | 2025 | 39177 | 0.050 |
Why?
| | Transgenes | 1 | 2004 | 186 | 0.050 |
Why?
| | Anticholesteremic Agents | 1 | 2005 | 155 | 0.050 |
Why?
| | Codon, Nonsense | 1 | 2023 | 43 | 0.050 |
Why?
| | Heart | 2 | 2022 | 620 | 0.050 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1402 | 0.050 |
Why?
| | Electrocardiography | 1 | 2025 | 618 | 0.050 |
Why?
| | Smad3 Protein | 1 | 2021 | 44 | 0.050 |
Why?
| | Smad2 Protein | 1 | 2021 | 39 | 0.040 |
Why?
| | RNA, Messenger | 3 | 2020 | 2828 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 86 | 0.040 |
Why?
| | Optical Tweezers | 1 | 2021 | 21 | 0.040 |
Why?
| | Animals, Genetically Modified | 3 | 2009 | 242 | 0.040 |
Why?
| | Nanotubes | 1 | 2021 | 46 | 0.040 |
Why?
| | Disease Progression | 1 | 2009 | 2793 | 0.040 |
Why?
| | Body Mass Index | 1 | 2009 | 2382 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 453 | 0.040 |
Why?
| | Rabbits | 3 | 2009 | 754 | 0.040 |
Why?
| | Actin Cytoskeleton | 1 | 2021 | 103 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2892 | 0.040 |
Why?
| | NFATC Transcription Factors | 2 | 2012 | 94 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2021 | 171 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2005 | 2070 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2009 | 5200 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 175 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2018 | 19 | 0.040 |
Why?
| | Elastic Modulus | 1 | 2018 | 123 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 579 | 0.030 |
Why?
| | RNA | 1 | 2023 | 930 | 0.030 |
Why?
| | Prognosis | 1 | 2005 | 4073 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2018 | 246 | 0.030 |
Why?
| | Algorithms | 1 | 2004 | 1763 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2520 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 863 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3490 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 660 | 0.030 |
Why?
| | Time Factors | 2 | 2021 | 6956 | 0.030 |
Why?
| | DNA, Mitochondrial | 2 | 2006 | 211 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2016 | 202 | 0.030 |
Why?
| | Family | 2 | 2007 | 680 | 0.020 |
Why?
| | Collagen | 2 | 2006 | 459 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 159 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 914 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2012 | 441 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 274 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2012 | 132 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2012 | 216 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 943 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2005 | 11120 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 464 | 0.020 |
Why?
| | Cell Size | 1 | 2009 | 89 | 0.020 |
Why?
| | Ventricular Fibrillation | 1 | 2009 | 62 | 0.020 |
Why?
| | Adolescent | 2 | 2024 | 22007 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13673 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2007 | 44 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 64 | 0.020 |
Why?
| | Penetrance | 1 | 2007 | 28 | 0.020 |
Why?
| | Glutathione | 1 | 2009 | 356 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 16273 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 325 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2007 | 288 | 0.020 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 163 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2007 | 238 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 391 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2009 | 464 | 0.020 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2006 | 21 | 0.020 |
Why?
| | Malondialdehyde | 1 | 2006 | 29 | 0.020 |
Why?
| | Procollagen | 1 | 2006 | 23 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 310 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2006 | 150 | 0.010 |
Why?
| | Nonmuscle Myosin Type IIB | 1 | 2004 | 7 | 0.010 |
Why?
| | Cytochrome P-450 CYP11B2 | 1 | 2004 | 1 | 0.010 |
Why?
| | Myofibrils | 1 | 2004 | 49 | 0.010 |
Why?
| | Spironolactone | 1 | 2004 | 34 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 987 | 0.010 |
Why?
| | Glutamine | 1 | 2004 | 107 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 150 | 0.010 |
Why?
| | Hypertrophy | 1 | 2004 | 136 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2004 | 156 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 183 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2180 | 0.010 |
Why?
| | Adenosine Triphosphatases | 1 | 2004 | 159 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 219 | 0.010 |
Why?
| | Cadherins | 1 | 2004 | 202 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2005 | 513 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2004 | 368 | 0.010 |
Why?
| | beta Catenin | 1 | 2004 | 258 | 0.010 |
Why?
| | Trans-Activators | 1 | 2004 | 388 | 0.010 |
Why?
| | Gene Expression | 1 | 2006 | 1491 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1444 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2005 | 1330 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1187 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2004 | 1764 | 0.010 |
Why?
| | Aging | 1 | 2004 | 1892 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 4174 | 0.010 |
Why?
| | Child | 1 | 2007 | 22308 | 0.000 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|